Rafarma Pharmaceuticals, Inc. Achieves Full Certification
Full Production expected in second quarter 2012
(PRWeb December 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10246154.htm

Full Production expected in second quarter 2012
(PRWeb December 17, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10246154.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
